Trevi Therapeutics, Inc. (TRVI) Insider Trading

Name: Trevi Therapeutics, Inc. (TRVI) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 17, 2026): Michael Thomas Heffernan (Director): Exercise/Conversion of 18,421 shares, $56.0K.

Get alerted when insiders trade TRVI

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta